The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Erkinova Sh.B.

Westminster International University in Tashkent

Babakhanov B.Kh.

Republican specialized scientific and practical medical centre for neurosurgery

Dzhalalov S.Ch.

Westminster International University in Tashkent

Cost-effectiveness of ventriculoperitoneal shunting versus endoscopic third ventriculostomy in the treatment of hydrocephalus

Authors:

Erkinova Sh.B., Babakhanov B.Kh., Dzhalalov S.Ch.

More about the authors

Journal: Medical Technologies. Assessment and Choice. 2021;43(3): 32‑36

DOI: 10.17116/medtech20214303132

Read: 3171 times

Download PDF (RU)
Contact the author
Table of contents

COST-EFFECTIVENESS OF VENTRICULOPERITONEAL SHUNTING VERSUS ENDOSCOPIC THIRD VENTRICULOSTOMY IN THE TREATMENT OF HYDROCEPHALUS
COST-EFFECTIVENESS OF VENTRICULOPERITONEAL SHUNTING VERSUS ENDOSCOPIC THIRD VENTRICULOSTOMY IN THE TREATMENT OF HYDROCEPHALUS

To cite this article:

Erkinova ShB, Babakhanov BKh, Dzhalalov SCh. Cost-effectiveness of ventriculoperitoneal shunting versus endoscopic third ventriculostomy in the treatment of hydrocephalus. Medical Technologies. Assessment and Choice. 2021;43(3):32‑36. (In Russ.)
https://doi.org/10.17116/medtech20214303132

Подписка 2026 Медицинские технологии. Оценка и выбор (Medical Technologies. Assessment and Choice)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Is arti­ficial inte­lligence nece­ssary for healthcare system?. Medi­cal Technologies. Asse­ssment and Choice. 2024;(4):40-48
Cost-effectiveness analysis of deno­sumab therapy in adults with solid tumors and bone meta­stases (in Russian healthcare). Medi­cal Technologies. Asse­ssment and Choice. 2024;(4):74-89
Economic issues of medi­cal care for hype­rparathyroidism. Part 1. Primary hype­rparathyroidism. Medi­cal Technologies. Asse­ssment and Choice. 2025;(1):51-61
Cost-effectiveness analysis of bariatric surgery in obese patients. Medi­cal Technologies. Asse­ssment and Choice. 2025;(1):62-75
Pharmacoeconomic analysis of the neta­kimab use for the treatment of psoriasis vulgaris in the health care settings of the Russian Fede­ration. Medi­cal Technologies. Asse­ssment and Choice. 2025;(2):99-105
Economics of hype­rparathyroidism. Part 2 — seco­ndary hype­rparathyroidism. Medi­cal Technologies. Asse­ssment and Choice. 2025;(3):74-82
Cost-effectiveness analysis of triptorelin therapy for patients with prostate cancer in state healthcare system of the Russian Fede­ration. Medi­cal Technologies. Asse­ssment and Choice. 2025;(3):83-92
Intracardiac migration of a ventriculoperitoneal shunt. A systematic lite­rature review and case report. Burdenko's Journal of Neurosurgery. 2024;(6):88-96
Exte­rnal vali­dation of the ETVSS scale for predicting the outcomes after third ventriculostomy in children less than one year of age with obstructive hydrocephalus. Burdenko's Journal of Neurosurgery. 2025;(5):45-53
Abstract:

OBJECTIVE

Review of cost-effectiveness studies of ventriculoperitoneal shunting (VPS) and endoscopic third ventriculostomy (EVS) in the treatment of hydrocephalus in children younger than 18 years.

MATERIAL AND METHODS

The authors summarized the studies devoted to economic evaluation of EVS and VPS in the treatment of hydrocephalus in children. Studies were searched in the PubMed database. The review includes 3 trials.

RESULTS

The studies were carried out in different countries and differ in design. In 2 studies, no significant differences were found in costs of EVS and VPS. In the third study, VPS was more expensive due to length of hospital stay, and EVS had a lower cost-effectiveness ratio compared to VPS ($ 94.797 and 130.839, respectively) but not among patients with myelomeningocele and post-hemorrhagic hydrocephalus. Incremental cost-effectiveness ratios were calculated in none of the studies. No studies were found in Central Asia including Uzbekistan.

CONCLUSION

A review of economic studies of hydrocephalus management revealed insufficient evidence to support cost-effectiveness of EVS or VPS.

Keywords:

endoscopic third ventriculostomy
ventriculoperitoneal shunting
quality-adjusted life-years
cost-effectiveness analysis

Authors:

Erkinova Sh.B.

Westminster International University in Tashkent

Babakhanov B.Kh.

Republican specialized scientific and practical medical centre for neurosurgery

Dzhalalov S.Ch.

Westminster International University in Tashkent

Received:

22.12.2020

Accepted:

27.05.2021

Close metadata

References:

  1. Bullivant K, Hader W, Hamilton M. A Pediatric Experience with Endoscopic Third Ventriculostomy for Hydrocephalus. Canadian Journal of Neuroscience Nursing. 2009;31(2):16-19. 
  2. Hydrocephalus Association (2018). Facts and Stats. Hydrocephalus Association. Accessed May 31, 2021. https://www.hydroassoc.org/about-us/newsroom/facts-and-stats-2/
  3. Pan I, Harris D, Luerssen T, Lam S. Comparative Effectiveness of Surgical Treatments for Pediatric Hydrocephalus. Neurosurgery. 2018;83(3):480-487.  https://doi.org/10.1093/neuros/nyx440
  4. Laeke T, Tirsit A, Biluts H, Murali D, Wester K. Pediatric Hydrocephalus in Ethiopia: Treatment Failures and Infections: A Hospital-Based, Retrospective Study. World Neurosurgery. 2017;100:30-37.  https://doi.org/10.1016/j.wneu.2016.12.112
  5. Li Ch, Gui S, Zhang Ya. Compare the Safety and Efficacy of Endoscopic Third Ventriculostomy and Ventriculoperitoneal Shunt Placement in Infants and Children with Hydrocephalus: a Systematic Review and Meta-analysis. International Journal of Neuroscience. 2017;1-30.  https://doi.org/10.1080/00207454.2017.1348352
  6. Bouras T, Sgouros S. Complications of Endoscopic Third Ventriculostomy. Journal of Neurosurgery. Pediatrics. 2011;7(6):643-649.  https://doi.org/10.3171/2011.4.PEDS10503
  7. Mixter WJ. Ventriculoscopy and Puncture of the Floor of the Third Ventricle — Preliminary Report of a Case. Boston Medical and Surgical Journal. 1923; 188:277-278.  https://doi.org/10.1056/NEJM192303011880909
  8. Kulkarni A, Drake J, Kestle J, Mallucci C, Sgouros S, Constantini S; Canadian Pediatric Neurosurgery Study Group. Predicting who will benefit from endoscopic third ventriculostomy compared with shunt insertion in childhood hydrocephalus using the ETV Success Score. Journal of Neurosurgery. Pediatrics. 2010;6(4):310-315.  https://doi.org/10.3171/2010.8.PEDS103
  9. Jeelani N, DeSilva P, Jeelani A, Thompson D, Hayward R. Childhood Hydrocephalus: a Snapshot of the Clinical workload and its Implications on the NHS Budget. Bulletin of the Royal College of Surgeons of England. 2011;93(3):1-6.  https://doi.org/10.1308/bull.2011.93.3.1
  10. Garton H, Kestle J, Cochrane D, Steinbok P. A Cost — Effectiveness Analysis of Endoscopic Third Ventriculostomy. Neurosurgery. 2002;51(1):69-78.  https://doi.org/10.1097/00006123-200207000-00012
  11. Lima B, Prateci R. Endoscopic Third Ventriculostomy has no Higher Costs than Ventriculoperitoneal Shunt. Arquivos de Neuro-Psiquiatria. 2014;72(7):524-527.  https://doi.org/10.1590/0004-282X20140070
  12. Lim J, Tang A, Liles C, Hysong A, Hale A, Bonfield CM, Naftel RP, Wellons JC, Shannon CN. The Cost of Hydrocephalus: a Cost-Effectiveness Model for Evaluating Surgical Techniques. Journal of Neurosurgery. Pediatrics. 2018;23(1):109-118.  https://doi.org/10.3171/2018.6.PEDS17654
  13. Cheng H, Hong WM, Mei ZhJ, Wang XJ. Surgical Management of Non-Communicating Hydrocephalus in Patients: Meta-analysis and Comparison of Endoscopic Third Ventriculostomy and Ventriculoperitoneal Shunt. The Journal of Craniofacial Surgery. 2015;26(2):481-486.  https://doi.org/10.1097/SCS.0000000000001467
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.